These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3721420

  • 41. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 45. Cognitive and neuropsychological characteristics of attention deficit hyperactivity disorder children receiving stimulant medications.
    Risser MG, Bowers TG.
    Percept Mot Skills; 1993 Dec; 77(3 Pt 1):1023-31. PubMed ID: 8284137
    [Abstract] [Full Text] [Related]

  • 46. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
    Wender PH.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 7():76-9. PubMed ID: 9680056
    [Abstract] [Full Text] [Related]

  • 47. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
    Wender PH, Wood DR, Reimherr FW.
    Psychopharmacol Bull; 1985 Dec; 21(2):222-31. PubMed ID: 3923527
    [No Abstract] [Full Text] [Related]

  • 48. Attention-deficit disorder. Born to be hyperactive?
    Zametkin AJ.
    JAMA; 1995 Jun 21; 273(23):1871-4. PubMed ID: 7776505
    [No Abstract] [Full Text] [Related]

  • 49. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK, Julius JR, Breen TJ, Blethen SL.
    Pediatrics; 1998 Aug 21; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [Abstract] [Full Text] [Related]

  • 50. Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis.
    Fargason RE, Ford CV.
    South Med J; 1994 Mar 21; 87(3):302-9. PubMed ID: 8134849
    [Abstract] [Full Text] [Related]

  • 51. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder.
    Levin FR, Evans SM, Kleber HD.
    Psychiatr Serv; 1999 Aug 21; 50(8):1001-3. PubMed ID: 10445644
    [No Abstract] [Full Text] [Related]

  • 52. Clonidine in attention deficit hyperactivity disorder.
    Hart-Santora D, Hart LL.
    Ann Pharmacother; 1992 Jan 21; 26(1):37-9. PubMed ID: 1606344
    [No Abstract] [Full Text] [Related]

  • 53. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D, Jarman F, Barker M.
    Pediatrics; 1997 Dec 21; 100(6):E6. PubMed ID: 9382907
    [Abstract] [Full Text] [Related]

  • 54. Clinical management of children with hyperactivity. A shift in diagnostic and therapeutic emphasis.
    Hesterly SO.
    Postgrad Med; 1986 Apr 21; 79(5):299-305. PubMed ID: 3960806
    [Abstract] [Full Text] [Related]

  • 55. Major treatment considerations for attention-deficit hyperactivity disorder.
    Safer DJ.
    Curr Probl Pediatr; 1995 Apr 21; 25(4):137-43. PubMed ID: 7641527
    [No Abstract] [Full Text] [Related]

  • 56. Hyperactive children treated with stimulants. Is cognitive training a useful adjunct?
    Abikoff H, Gittelman R.
    Arch Gen Psychiatry; 1985 Oct 21; 42(10):953-61. PubMed ID: 2864027
    [Abstract] [Full Text] [Related]

  • 57. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
    Heiligenstein E, Johnston HF, Nielsen JK.
    J Am Coll Health; 1996 Jul 21; 45(1):35-9. PubMed ID: 8708264
    [Abstract] [Full Text] [Related]

  • 58. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE, Gadow KD, Sprafkin J.
    Pediatrics; 1999 Apr 21; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [Abstract] [Full Text] [Related]

  • 59. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
    Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL.
    Neuropsychopharmacology; 1996 Feb 21; 14(2):125-37. PubMed ID: 8822535
    [Abstract] [Full Text] [Related]

  • 60. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
    Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M.
    J Child Adolesc Psychopharmacol; 2000 Feb 21; 10(3):205-16. PubMed ID: 11052410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.